Jean-Francois Tardif Syneron Medical Ltd. ELOS-Q PAST TOP PICK Jun 01, 2005

(A Top Pick Feb3/05. Up 20%.) Still likes. Trying to get approval on a new product. Analysts forcast for next year is $1.60 but he believes it could be as high as $2.50/3.00.

Jean-Francois Tardif

Owned

Unlock Rating

$34.860

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Health and cosmetic industry is growing very strong. Company is very innovative. In '04, their earnings grew about 100%. Have $3 cash per share. Will be launching a new product for sunlight. Trades at 25 X current earnings.

TOP PICK

Sells machines to health care clinics. Just got approval from the FDA for a cellulite product. Expects great demand. Earnings have been rising very rapidly. Low multiples.

TOP PICK

Recently, the stock was hit pretty hard because of lower than expected earnings forecast. Thinks they will make $2/2.20 a share in ’06. They have $5 in cash per share. Not very expensive.

PAST TOP PICK

(A Top Pick Feb 15/06. Up 6%.) The beauty treatment sector is doing very well. Still likes.

WATCH

Still likes it, but there are some worrisome things. Have lost some top level management. The earnings are growing, have a great balance sheet and lots of cash. Waiting to see what the next quarter brings. Trading around 10 X earnings which is not expensive.

PAST TOP PICK

(A Top Pick Feb 15/06. Down 27%.) Disappointed two quarters in a row. Forward expectations by US analysts have dropped. Have sold some shares. The industry is doing well. He'll wait for one more quarter.

WATCH

Have about $6 of cash per share. Earnings should be $1.60. Missed 2 quarters in a row and the stock took a hit. Some key people have left. Has created doubt, but the trend in the industry is very good. He sold his holdings. Would buy if they start growing again.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jean-Francois Tardif Syneron Medical Ltd. ELOS-Q PAST TOP PICK Jun 01, 2005

You might be interested:

Syneron Medical Ltd.(ELOS-Q)

Syneron Medical Ltd.(ELOS-Q)

Syneron Medical Ltd.(ELOS-Q)

Syneron Medical Ltd.(ELOS-Q)

Syneron Medical Ltd.(ELOS-Q)

Syneron Medical Ltd.(ELOS-Q)

Syneron Medical Ltd.(ELOS-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Chris Blumas

Stockchase Insights

Jim Cramer - Mad Money

Eric Nuttall

The Panic-Proof Portfolio (Stockchase Research)